| Patents for C07C 275 - Derivatives of urea, i.e. compounds containing any of the groups the nitrogen atoms not being part of nitro or nitroso groups (9,848) |
|---|
| 07/06/2006 | US20060148760 Method for the sysnthesis of compounds of formula I and their uses thereof |
| 07/05/2006 | EP1675822A2 Amide or thioamide derivatives and their use in the treatment of pain |
| 07/05/2006 | EP1675821A1 Phenetanolamine derivatives |
| 07/05/2006 | EP1675587A2 Derivatives of n-(1h-indazolyl)- and n-(1h-indolyl)-urea as well as related compounds as modulators of the vanilloid-1 receptor (vr1) for the treatment of pain |
| 07/05/2006 | CN1798742A Novel biaromatic compounds which activate ppar [upsilon] pharmaceutical compsns |
| 07/05/2006 | CN1798732A Substituted tetralins and indanes |
| 07/05/2006 | CN1798731A Ionic liquid comprising uronium cations or thiouronium cations |
| 07/05/2006 | CN1798730A Carbonylamino-substituted acyl phenyl urea derivatives, process for their preparation and their use |
| 07/04/2006 | US7071353 Catalytically reacting isocyanates with aromatic carboxylic acid to for colorless, unfoamed products |
| 07/04/2006 | US7071231 Especially Type II diabetes; stimulating the kinase activity of the insulin receptor; activating the insulin receptor |
| 07/04/2006 | US7071211 Vision disorders; adjustment activation of gelatinase |
| 06/28/2006 | CN1795175A Acetylene derivatives as inhibitors of histone deacetylase |
| 06/27/2006 | US7067697 introducing a biologically active agent into a cell of a plant or animal comprising: contacting said cell with lipid vesicles comprising amino acid amide lipids in vivo or in vitro; gene therapy |
| 06/27/2006 | US7067554 Method for the synthesis of compounds of formula I and their uses thereof |
| 06/27/2006 | US7067517 Use of compounds for decreasing activity of hormone-sensitive lipase |
| 06/22/2006 | WO2006063654A1 Method for producing onium alkyl sulfates with a low halogenide content |
| 06/22/2006 | WO2006063653A1 Method for the production of onium salts with tetrafluoroborate anion having a reduced halide content |
| 06/22/2006 | US20060135505 N-(7-hydroxy-5,6,7,8-tetrahydronaphthalen-1-yl)-N'-[3-piperidin-1-yl-4-(trifluoromethyl)benzyl]urea; urinary incontinence, overactive bladder, pain, nerve injury, ischemia, neurodegeneration, stroke, inflammatory disorders, asthma and chronic obstructive pulmonary disease |
| 06/22/2006 | US20060135503 Cyclic amide derivative as monocyte chemotactic protein modulator; prevention and treatment of rheumatoid arthritis, multiple sclerosis, atherosclerosis and asthma; antiinflammatory agents; N-[2-[[(cis) -2-[[1- (4-Chlorophenyl)ethyl]amino]cyclohexyl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide |
| 06/22/2006 | DE102004060739A1 Preparation of polyisocyanate containing biuret group comprises mixing di- and/or polyisocyanate; water (vapor) as biuret-forming agent; optionally catalyst, in a mixing device and leading the obtained reaction mixture into a reactor |
| 06/22/2006 | CA2590780A1 Process for the preparation of onium salts with a tetrafluoroborate anion having a reduced halide content |
| 06/21/2006 | EP1556436B1 Polyamine derivatives, a process to make them, and their use |
| 06/21/2006 | EP1100770B1 Monomers and network polymers obtained therefrom |
| 06/21/2006 | EP1049662B1 Inhibitors of alpha4 mediated cell adhesion |
| 06/21/2006 | CN1791572A Novel compounds |
| 06/20/2006 | US7064229 Succinic acid derivatives |
| 06/15/2006 | WO2006062580A1 Indane amides with antiproliferative activity |
| 06/15/2006 | US20060128957 Fluorous tagging and scavenging reactants and methods of synthesis and use thereof |
| 06/15/2006 | US20060128704 2-Hydroxy-1,2,3,4-tetrahydronaphthalenes substituted in the 8-position with a biphenylcarbonylamino-, biphenylcarbonylaminoalkyl-, biphenylaminocarbonylamino-, or biphenylaminocarbonylaminoalkyl- group; vanilloid receptor antagonists |
| 06/15/2006 | US20060128633 Colchinol derivatives as vascular damaging agents |
| 06/15/2006 | CA2584307A1 Indane amides with antiproliferative activity |
| 06/14/2006 | EP1668086A2 Low-cure powder coatings and methods for using the same |
| 06/14/2006 | EP1667966A1 N-alkylated diaminopropane derivatives as modulators of chemokine receptor activity |
| 06/14/2006 | EP1102742B1 Compounds and compositions for delivering active agents |
| 06/14/2006 | CN1259306C Process for the preparation of aminoalcohol, aminoalcohol derivatives and their further conversion to (1S, 4R)-4-(2-AMINO - 6-CHLORO - 9- H - PURINE - 9-YL)-2- CYCLOPENTENYL-1-METHANOL or its salt |
| 06/13/2006 | US7060851 Method of preparing retroviral protease inhibitor intermediates |
| 06/13/2006 | US7060850 Fluorous tagging and scavenging reactants and methods of synthesis and use thereof |
| 06/13/2006 | US7060845 Stabilized activated derivatives of carbamic acid, their process of preparation and their use for the preparation of ureas |
| 06/08/2006 | US20060122416 1,2-bis(6-(ethylhexyloxycarbonylamino)hexylaminocarbonylamino)cyclohexane; gelling agents for hot melt and phase change inks |
| 06/08/2006 | US20060122415 Processes for preparing bis(urea-urethane) compounds |
| 06/08/2006 | US20060121090 Ocular compositions that increases the activity of gelatinase a in ocular cells |
| 06/08/2006 | DE102004058173A1 Lagerstabile aliphatische, cycloaliphatische oder (cyclo)aliphatische Diisocyanate Storage-stable aliphatic, cycloaliphatic or (cyclo) aliphatic diisocyanates |
| 06/08/2006 | DE102004056849A1 Neue Polyisocyanatgemische, ein Verfahren zu ihrer Herstellung und ihre Verwendung als Härterkomponente in Polyurethanlacken New polyisocyanate, a process for their preparation and their use as a curing component in polyurethane lacquers |
| 06/07/2006 | EP1666457A1 Trans-1,2-cyclohexane bis(urea-urethane) compounds |
| 06/07/2006 | EP1666456A1 Bis(urea-urethane) compounds and phase change inks containing same |
| 06/07/2006 | EP1664316A1 Polyethyleneglycol-modified lipid compounds and uses thereof |
| 06/07/2006 | CN1781903A Process for the preparation of tetrasubstituted imidazole derivatives and novel crystalline structures thereof |
| 06/06/2006 | US7056902 4-dedimethylamino tetracycline compounds |
| 06/01/2006 | DE102004057916A1 Blocked polyisocyanate for dual-cure coating, contains radiation-curable group(s) and specific structural unit(s) |
| 05/31/2006 | EP1660859A2 T1r hetero-oligomeric taste receptors, cell lines that express said receptors, and taste compounds |
| 05/31/2006 | EP1659881A2 Novel flavors, flavor modifiers, tastants, taste enhancers, umami or sweet tastants, and/or enhancers and use thereof |
| 05/31/2006 | EP1263825B1 Aqueous composition that can be hardened physically, thermally or thermally and with actinic radiation and the derivatives and production thereof |
| 05/31/2006 | CN1780811A Diphenylethylene compounds and uses thereof |
| 05/31/2006 | CN1778287A Increased moisturization efficacy using hydroxyalkylurea |
| 05/30/2006 | US7053244 Method for the continuous production of tetra-substituted ureas |
| 05/30/2006 | US7053243 3-Methoxybenzyl thiourea derivatives and improved lipid compositions containing same |
| 05/30/2006 | US7053234 Antibacterial agents |
| 05/30/2006 | US7052655 Separating unreacted ammonia and unreacted carbon dioxide from the reaction mixture by stripping the mixture with the carbon dioxide feedstock at a pressure equal to the urea synthesis pressure |
| 05/30/2006 | CA2161246C Fullerene derivatives, methods of preparing them and their use |
| 05/26/2006 | WO2006004613A3 Guanylhydrazone salts, compositions, processes of making and methods of using |
| 05/25/2006 | US20060110343 Cosmetic or dermopharmaceutical compositions comprising tyramine derivatives, method for preparing same, and use thereof |
| 05/24/2006 | EP1658263A1 Novel aminobenzophenone compounds |
| 05/24/2006 | CN1777591A Methods for producing phenylalanine derivatives having a quinazolinedione skeleton and intermediates for production thereof |
| 05/24/2006 | CN1777577A Antibacterial agents |
| 05/23/2006 | US7049341 Antidiabetic agents |
| 05/23/2006 | US7049317 CCR-3 receptor antagonists |
| 05/18/2006 | WO2006052722A1 Glycogen phosphorylase inhibitor compounds and pharmaceutical compositions thereof |
| 05/18/2006 | WO2006050800A1 4-amino-5-oxo-8-phenyl-5h-pyrido-[2,3-d]-pyrimidine derivatives as tyrosine kinase and raf kinase inhibitors for the treatment of tumours |
| 05/18/2006 | US20060106071 Substituted amides |
| 05/18/2006 | CA2587609A1 4-amino-5-oxo-8-phenyl-5h-pyrido[2,3-d]pyrimidine derivatives as tyrosine kinase and raf kinase inhibitors for the treatment of tumours |
| 05/18/2006 | CA2586446A1 Glycogen phosphorylase inhibitor compounds and pharmaceutical compositions thereof |
| 05/18/2006 | CA2579227A1 Arylalkyl ureas as cb1 antagonists |
| 05/17/2006 | EP1657243A1 Procedure for the production of amino alcohols |
| 05/17/2006 | EP1656348A1 Acetylene derivatives as inhibitors of histone deacetylase |
| 05/17/2006 | EP1656341A1 Prodrugs of 9-aminomethyl tetracycline compounds |
| 05/17/2006 | EP1656138A2 Substituted cycloalkyamine derivatives as modulators of chemokine receptor activity |
| 05/16/2006 | US7045533 Such as naphthalen-1-yl-(4-pentyloxy-naphthalen-1-yl)-mehtane for treatment/prevention of diseases/conditions associated with cannobinoid receptor activation such as chronic pain, osteo- and rheumatoid arthritis, teno-synovitis and gout |
| 05/16/2006 | US7045532 ACE-2 modulating compounds and methods of use thereof |
| 05/10/2006 | CN1771249A Pyrazolidine-1,2-dicarboxyldiphenylamide derivatives as coagulation factor xa inhibitors for the treatment of thromboses. |
| 05/10/2006 | CN1771248A Pyrazolidine-1,2-dicarboxyldiphenylamide derivatives as coagulation factor xa inhibitors for the treatment of thromboses. |
| 05/10/2006 | CN1771237A Pyrazolidine-1,2-dicarboxyldiphenylamide derivatives as coagulation factor xa inhibitors for the treatment of thromboses. |
| 05/09/2006 | CA2257328C Thiazole derivatives |
| 05/04/2006 | US20060094786 Treating syndrome X with substituted tetralins and indanes |
| 05/04/2006 | US20060094769 e.g. methyl 4-{[(5-ethoxy-5-oxopentyl)(2-methoxyphenethyl)amino]methyl}benzoate; stimulant of guanylate cyclase; catalyse the biosynthesis of cGMP from guanosine triphosphate (GTP); cardiovascular disorders; liver fibrosis |
| 05/04/2006 | US20060094708 to treat cellular proliferative diseases, hyperplasias, solid tumor, cardiac hypertrophy, immune disorders and inflammation; modulators of one or more mitotic kinesins; N-(2-(2-dimethylamino-acetylamino)-1-{4-[8-(1-hydroxy-ethyl)-imidazo[1,2-a]pyridin-2-yl]-benzyl}-ethyl)-3-chloro-4-isopropoxy-benzamide |
| 05/04/2006 | US20060091351 suitable for treating (particularly surface-treating) various substrates such as a textile; heat resistance, oxidation resistance and weather resistance |
| 05/03/2006 | EP1652837A1 Aminocarbonyl naphthol derivative, cyanonaphthol derivative, and method for producing them |
| 05/03/2006 | EP1651595A2 Ubiquitin ligase inhibitors |
| 05/03/2006 | EP1252135B8 Esters of fatty acids and juvenoid alcohols, and a method of their preparation and use |
| 05/03/2006 | EP1208091B1 Benzophenones as inhibitors of reverse transcriptase |
| 05/03/2006 | CN1767823A Asthma and allergic inflammation modulators |
| 05/02/2006 | US7038074 Arginine mimetics as factor Xa inhibitors |
| 05/02/2006 | US7038003 Polyether allophanates stable towards discolouration |
| 05/02/2006 | US7037942 Amide compounds for the potentiation of cholinergic activity |
| 04/27/2006 | US20060089414 Generic probes for the detection of phosphorylated sequences |
| 04/27/2006 | US20060089336 4-Dedimethylamino tetracycline compounds |
| 04/27/2006 | DE102004051026A1 Kristallisationsstabile MDI-Allophanate nach einem zweistufigen Verfahren Stable crystallization MDI allophanates according to a two step process |
| 04/26/2006 | EP1648859A2 Substituted tetracycline compounds |
| 04/26/2006 | CN1762988A Blocked biuretized isocyanates |
| 04/26/2006 | CN1762987A Biuretized polyisocyanates and blocked biuretized polyisocyanates |